drugset / Trial / NCT01202097
A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective will be to compare the formulations regarding their impact on the pulmonary function of persistent asthma patients and the secondary objective will be the clinical control of the disease's symptoms.
Timeline
- Start
- 2011-08
- Primary completion
- —
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salmeterol/Fluticasone | Unknown | 50 ug | Inhaled |
| Comparator | Salmeterol/Fluticasone | Unknown | 50 ug | Inhaled |
| Subject | Salmeterol/Fluticasone | Unknown | 250 ug | Inhaled |
| Comparator | Salmeterol/Fluticasone | Unknown | 250 ug | Inhaled |